These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Glucocorticoid and Bone. Updated Japanese guidelines for the management of glucocorticoid-induced osteoporosis]. Suzuki Y Clin Calcium; 2014 Sep; 24(9):1309-18. PubMed ID: 25177003 [TBL] [Abstract][Full Text] [Related]
4. [Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis]. Suzuki Y; Wakabayashi T Clin Calcium; 2015 Dec; 25(12):1825-34. PubMed ID: 26608858 [TBL] [Abstract][Full Text] [Related]
5. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis]. Suzuki Y Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939 [TBL] [Abstract][Full Text] [Related]
6. [Assessment of the treatment of glucocorticoid-induced osteoporosis]. Asano S; Suzuki A Clin Calcium; 2013 Mar; 23(3):401-8. PubMed ID: 23445894 [TBL] [Abstract][Full Text] [Related]
7. [Glucocorticoid and Bone. The changes of Japanese and foreign guidelines for the management of glucocorticoid-induced osteoporosis]. Soen S Clin Calcium; 2014 Sep; 24(9):1301-8. PubMed ID: 25177002 [TBL] [Abstract][Full Text] [Related]
9. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems]. Soen S Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions. Bultink IE; Baden M; Lems WF Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448 [TBL] [Abstract][Full Text] [Related]
11. [Management of glucocorticoid-induced osteoporosis]. Soen S Clin Calcium; 2005 Apr; 15(4):616-24. PubMed ID: 15802774 [TBL] [Abstract][Full Text] [Related]
12. [Glucocorticoid and bone]. Soen S Clin Calcium; 2014 Jun; 24(6):829-36. PubMed ID: 24870833 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis]. Soen S Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297 [TBL] [Abstract][Full Text] [Related]
14. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis. Boling EP Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513 [TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. De Nijs RN Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694 [TBL] [Abstract][Full Text] [Related]
17. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis]. Suzuki Y; Sato S Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275 [TBL] [Abstract][Full Text] [Related]
18. [Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis]. Yamamoto M; Sugimoto T Clin Calcium; 2014 Sep; 24(9):1379-85. PubMed ID: 25177011 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis. Pereira RM; Carvalho JF; Paula AP; Zerbini C; Domiciano DS; Gonçalves H; Danowski JS; Marques Neto JF; Mendonça LM; Bezerra MC; Terreri MT; Imamura M; Weingrill P; Plapler PG; Radominski S; Tourinho T; Szejnfeld VL; Andrada NC; ; ; Rev Bras Reumatol; 2012 Aug; 52(4):580-93. PubMed ID: 22885424 [TBL] [Abstract][Full Text] [Related]
20. [Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios]. Di Munno O; Delle Sedie A Reumatismo; 2011; 63(2):67-79. PubMed ID: 21776442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]